Algorithmic approach to rising PSA after curative prostate cancer treatmentLevent Mert Günay
regardless of the stage of prostate cancer. Once you get the new PSA in 30-days, you will be advised how to proceed. Again these products are not a cure and you will remain on these products the
Sometimes No Treatment is Best Option for Low-Risk Prostate CancerMarch 22, 2006 Find Life-Threatening Prostate Cancer Via PSA Velocity During "Window of Curability"Nov 1, 2006 Treating Prostate Cancer in Elderly Men Extends Lives Compared to "Watchful Waiting"Dec 13, 2006 ...
Brachytherapy After Beam Radiation Cures 3 out of 4 Prostate Cancer Patients January 5, 2007 For Early-Stage Prostate Cancer Patients, Good 8-Year Survival Rates with Seed Implants Alone Feb 7, 2007 Find Life-Threatening Prostate Cancer by Measuring PSA Velocity During a "Window of Curability" ...
Pomegranate juice has been associated with PSA doubling time (PSADT) elongation in a single-arm phase II trial. This study assesses biological activity of two doses of pomegranate extract (POMx) in men with recurrent prostate cancer, using changes in PSADT as the primary outcome. Methods: This...
SummaryBackground How best to treat rising prostate-specific antigen (PSA) concentration after radical prostatectomy is an urgent clinical question. Salvage radiotherapy delays the need for more aggressive treatment such as long-term and... Christian,Carrie,Ali,... - 《Lancet Oncology》 被引量: 66...
aAfter treatment, it is the panel’s view that a single PSA meas-urement at or near the lower detection limit of the assay is not sufficient to diagnose recurrence of prostate cancer. Rising PSA levels demonstrated by repeat or serial measurements provide much more reliable evidence (121, ...
(2005) Rising prostate specific antigen (PSA) during follow-up of prostate cancer patients — what to do?. European Journal of Cancer Supplements 3 , 309-315 /Fritz H.Schröder. (2005) Rising prostate specific antigen (PSA) during follow-up of prostate cancer patients — what to do?. ...
Prognosis based on postoperative PSA levels and treatment in prostate cancer with lymph node involvement PROSTATE-specific antigenPROSTATE cancerBackground: The therapeutic role of pelvic lymph node dissection (PLND) during radical prostatectomy (RP) for prostate ... T Tanegashima,M Shiota,T Kimura,....
glycosylation; glycans; prostate cancer; prostate specific antigen; biomarkers1. Introduction Prostate cancer was the second most commonly occurring cancer and the fifth leading cause of cancer death among men in 2020 [1,2]. In 1986, prostate-specific antigen (PSA) was approved by the United ...